C. Nestle-Krämling

发表

Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast Cancer

T. Fehm, S. Corradini, C. Matuschek, 2022, Cancers.

Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype

Julian Peto, Ute Hamann, Peter Devilee, 2005, Clinical Cancer Research.

Conservative mastectomies and Immediate-DElayed AutoLogous (IDEAL) breast reconstruction: the DIEP flap.

M. Otte, B. Munder, C. Andree, 2016, Gland surgery.

Erratum to: Breast reconstruction after neoadjuvant radio chemotherapy: review and personal technique IDEAL concept

W. Budach, E. Bölke, C. Andree, 2016, European Journal of Medical Research.

Breast reconstruction after neoadjuvant radio chemotherapy: review and personal technique IDEAL concept REV-EJMR-D-15-00268

W. Budach, E. Bölke, C. Andree, 2016, European Journal of Medical Research.

Novel cGMP liposomal vectors mediate efficient gene transfer

A. Hemminki, G. Bauerschmitz, P. Dall, 2003, Cancer Gene Therapy.

Oncoplastic surgical techniques in breast-conserving therapy for carcinoma of the breast

M. Rezai, C. Nestle-Krämling, 1999, Der Gynäkologe.

Therapy possibilities for locoregional recurrences in breast cancer

M. Untch, H. Hepp, C. Nestle-Krämling, 1999, Der Gynäkologe.

Limited relevance of the CHEK2 gene in hereditary breast cancer

A. Meindl, R. Schmutzler, M. Kiechle, 2004, International journal of cancer.

Use of different techniques of reduction mammoplasty in the total concept of oncological breast surgery

M. Untch, H. Hepp, C. Nestle-Krämling, 1999, Der Gynäkologe.

Skin-sparing mastectomy and immediate reconstruction with DIEP flap after breast-conserving therapy

B. Munder, W. Audretsch, C. Andree, 2012, Medical science monitor : international medical journal of experimental and clinical research.

Evaluation of mathematical models for breast cancer risk assessment in routine clinical use

M. Bani, M. Lux, M. Beckmann, 2007, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Risk reducing mastectomy: outcomes in 10 European centres

A. Howell, P. Møller, D. Eccles, 2008, Journal of Medical Genetics.

The benefit of adjuvant radiotherapy after breast conserving surgery in older patients with low risk breast cancer- a meta-analysis of randomized trials

S. Corradini, C. Matuschek, W. Budach, 2017, Radiation Oncology.

Adjuvant radiation therapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials- an update

C. Matuschek, W. Budach, P. Gerber, 2015, Radiation Oncology.

The benefit of adjuvant radiotherapy after breast conserving surgery in older patients with low risk breast cancer- a meta-analysis of randomized trials

S. Corradini, C. Matuschek, W. Budach, 2017, Radiation oncology.

[Prophylactic mastectomy in women at high risk for breast and ovarian cancer: qualitative analysis of the decision making process and long-term satisfaction of two women carrying a BRCA1-mutation].

I. Bauerfeind, M. Untch, A. Vodermaier, 2006, Psychotherapie, Psychosomatik, medizinische Psychologie.

Hormone Replacement Therapy after Treatment of Breast Cancer: Effects on Postmenopausal Symptoms, Bone Mineral Density and Recurrence Rates

M. Beckmann, P. Dall, H. Bender, 2001, Oncology.

Adjuvant radiation therapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials- an update

C. Matuschek, W. Budach, P. Gerber, 2015, Radiation oncology.

[Hemangiosarcoma after breast-conserving therapy of breast cancer: report of four cases with molecular genetic diagnosis and literature review].

S. Baldus, C. Eisenberger, W. Knoefel, 2011, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Factors Influencing Residual Glandular Breast Tissue after Risk-Reducing Mastectomy in Genetically Predisposed Individuals Detected by MRI Mammography

T. Fehm, G. Antoch, K. Jannusch, 2023, Cancers.

Use of intensified early cancer detection in high-risk patients with familial breast and ovarian cancer

P. Fasching, M. Lux, D. Niederacher, 2005, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Cancer in the family and implications for hormone replacement therapy

M. Beckmann, P. Fasching, P. Fasching, 2002 .

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†.

M. Rezai, T. Fehm, T. Kühn, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Age of uptake of early cancer detection facilities by low-risk and high-risk patients with familial breast and ovarian cancer

M. Bani, M. Lux, M. Beckmann, 2005, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Role of Breast Surgery in BRCA Mutation Carriers

T. Kühn, C. Nestle-Krämling, C. Nestle-Krämling, 2012, Breast Care.

Prophylaktische Chirurgie bei Brust- und Eierstockkrebsrisiko. Ein Überblick über die internationale Forschungsliteratur zu Einstellungen, Inanspruchnahmeverhalten und Lebensqualität

A. Vodermaier, I. Bauerfeind, C. Nestle-Krämling, 2006 .

Impact of surgical variables on residual glandular tissue in risk-reducing mastectomies: Results of a retrospective monocentric study from a center of the German consortium for hereditary breast and ovarian cancer.

K. Jannusch, L. Sawicki, N. Bruckmann, 2023, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.